Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF) (“BevCanna” or the “Company”) is pleased to announce that Chief Commercialization Officer Emma Andrews, RHN, NPDP, will be featured at this week’s International Cannabis Business Conference (ICBC), representing BevCanna’s insights into the infused beverage category. The conference is being held on September 15-16, 2019 at Vancouver’s Westin Bayshore Hotel.
Ms. Andrews will bring her expertise in developing cannabis-infused products and launching products in regulated industries to the panel Upcoming Regulatory Model: Edibles, Topicals and Extracts. Ms. Andrew’s co-panelists will include Niel Marotta, President and CEO, Director and Founder of Indiva; Brandon Wright, CEO of Dynaleo; and Bert Hick, President of Rising Tide Consultants. The panel will be moderated by Kirk Tousaw, of Tousaw Law Corporation.
“BevCanna has developed an opportunity-based perspective on the cannabis regulation discussion,” said Ms. Andrews. “Compliance is at the forefront of everyone’s mind as the legalization of infused beverages fast approaches in Canada, however there is still room for creativity and innovation. Sharing our unique expertise and insights, gained through years of experience developing market-leading products and navigating highly-regulated industries, helps advance the nascent cannabis-infused edibles and beverages category.”
BevCanna will also provide conference participants with samples of its alkaline spring water, sourced from their on-site aquifer in Bridesville, BC. The same premium spring water will soon be infused with cannabinoids, once regulations come into effect.
In addition to providing thought-leadership through events like ICBC, BevCanna is also a member of the Cannabis Beverage Producers Alliance, a unified body of manufacturers, industry professionals, and advisers who advocate for the safe, reliable and responsible production of legal cannabis beverages. The CBPA also acts as the voice of consumers; lobbying for the right to allow for responsible consumption choices within a framework of wide legal access, all the while ensuring public safety.
About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles per shift/per annum. BevCanna’s vision is to be a global leader in infused innovations.
Disclaimer for Forward-Looking Information
This news release contains forward-looking statements under applicable securities laws, including the statements that: legalization of infused beverages is fast approaching in Canada; BevCanna will provide conference participants with samples of its alkaline spring water, sourced from their on-site aquifer in Bridesville, BC, and the same premium spring water will soon be infused with cannabinoids, once regulations come into effect; and that BevCanna’s vision is to be a global leader in infused innovations.
These statements are based on certain assumptions regarding anticipated changes to Canadian federal legislation to legalize infused beverages; the continued normalization of cannabis-infused beverage consumption habits; and the issuances of licences by Health Canada to the Company. Readers are cautioned not to place undue reliance on forward-looking statements. The assumptions of the Company, although considered reasonable by it at the time of preparation, may prove to be incorrect. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with future legislative and regulatory developments; the Company not being issued licences by Health Canada; and other risks. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.